You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 275 No. 9, March 6, 1996 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation

E. R. Greenberg, J. A. Baron, M. R. Karagas, T. A. Stukel, D. W. Nierenberg, M. M. Stevens, J. S. Mandel and R. W. Haile
Dartmouth Medical School and Norris Cotton Cancer Center, Lebanon, NH, USA.

OBJECTIVE: To examine the relationship between beta carotene plasma concentration and beta carotene supplementation and risk of death from major disease causes. DESIGN: Cohort study of plasma concentrations; randomized, controlled clinical trial of supplementation. SETTING: Medical school-affiliated dermatology practices. PATIENTS: A total of 1188 men and 532 women with mean age of 63.2 years, who had enrolled in a randomized clinical trial of beta carotene supplementation to prevent nonmelanoma skin cancer. INTERVENTION: Oral beta carotene, 50 mg per day for a median of 4.3 years. MAIN OUTCOME MEASURES: All-cause mortality and mortality from cardiovascular disease and cancer. RESULTS: During a median follow-up period of 8.2 years, there were 285 deaths. Persons whose initial plasma beta carotene concentrations were in the highest quartile (>0.52 micromol/L [27.7 microg/dL]) had a lower risk of death from all causes (adjusted relative rate [RR], 0.52; 95% confidence interval [CI] 0.44 to 0.87) and from cardiovascular diseases (adjusted RR, 0.57; 95% CI, 0.34 to 0.95) compared with persons with initial concentrations in the lowest quartile (<0.21 micromol/L [11.2 microg/dL]). Patients randomly assigned to beta carotene supplementation showed no reduction in relative mortality rates from all causes (adjusted RR, 1.03; 95% CI, 0.82 to 1.30) or from cardiovascular disease (adjusted RR, 1.16; 95% CI, 0.82 to 1.64). There was no evidence of lower mortality following supplementation among patients with initial beta carotene concentrations below the median for the study group. CONCLUSIONS: These analyses provide no support for a strong effect of supplemental beta carotene in reducing mortality from cardiovascular disease or other causes. Although the possibility exists that beta carotene supplementation produces benefits that are too small or too delayed to have been detected in this study, noncausal explanations should be sought for the association between plasma concentrations of beta carotene and diminished risk of death.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Role of Oxidants and Antioxidants in Atherosclerosis: Results of In Vitro and In Vivo Investigations
Siekmeier et al.
J CARDIOVASC PHARMACOL THER 2007;12:265-282.
ABSTRACT  

A Randomized Factorial Trial of Vitamins C and E and Beta Carotene in the Secondary Prevention of Cardiovascular Events in Women: Results From the Women's Antioxidant Cardiovascular Study
Cook et al.
Arch Intern Med 2007;167:1610-1618.
ABSTRACT | FULL TEXT  

Beta Carotene Supplementation and Age-Related Maculopathy in a Randomized Trial of US Physicians
Christen et al.
Arch Ophthalmol 2007;125:333-339.
ABSTRACT | FULL TEXT  

National Institutes of Health State-of-the-Science Conference Statement: Multivitamin/Mineral Supplements and Chronic Disease Prevention
NIH State-of-the Science Panel
Am. J. Clin. Nutr. 2007;85:257S-264S.
FULL TEXT  

Clinical trials and observational studies to assess the chronic disease benefits and risks of multivitamin-multimineral supplements
Prentice
Am. J. Clin. Nutr. 2007;85:308S-313S.
ABSTRACT | FULL TEXT  

National Institutes of Health State-of-the-Science Conference Statement: Multivitamin/Mineral Supplements and Chronic Disease Prevention
NIH State-of-the-Science Panel*
ANN INTERN MED 2006;145:364-371.
FULL TEXT  

Carotenoids and cardiovascular health
Voutilainen et al.
Am. J. Clin. Nutr. 2006;83:1265-1271.
ABSTRACT | FULL TEXT  

Essential Nutrients: Food or Supplements?: Where Should the Emphasis Be?
Lichtenstein and Russell
JAMA 2005;294:351-358.
ABSTRACT | FULL TEXT  

Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts
Knekt et al.
Am. J. Clin. Nutr. 2004;80:1508-1520.
ABSTRACT | FULL TEXT  

Reflections on the Landmark Studies of {beta}-Carotene Supplementation
Duffield-Lillico and Begg
JNCI J Natl Cancer Inst 2004;96:1729-1731.
FULL TEXT  

Nutrition and Physical Activity and Chronic Disease Prevention: Research Strategies and Recommendations
Prentice et al.
JNCI J Natl Cancer Inst 2004;96:1276-1287.
ABSTRACT | FULL TEXT  

Antioxidant Vitamin Supplements and Cardiovascular Disease
Kris-Etherton et al.
Circulation 2004;110:637-641.
FULL TEXT  

Low Plasma Lycopene Concentration is Associated with Increased Mortality in a Cohort of Patients with Prior Oral, Pharynx or Larynx Cancers
Mayne et al.
J. Am. Coll. Nutr. 2004;23:34-42.
ABSTRACT | FULL TEXT  

Progression of Carotid Intima-Media Thickness and Plasma Antioxidants: The Los Angeles Atherosclerosis Study
Dwyer et al.
Arterioscler. Thromb. Vasc. Bio. 2004;24:313-319.
ABSTRACT | FULL TEXT  

Multivitamin Supplements Are Inversely Associated with Risk of Myocardial Infarction in Men and Women--Stockholm Heart Epidemiology Program (SHEEP)
Holmquist et al.
J. Nutr. 2003;133:2650-2654.
ABSTRACT | FULL TEXT  

Incidence of Cancer and Mortality Following {alpha}-Tocopherol and {beta}-Carotene Supplementation: A Postintervention Follow-up
The ATBC Study Group
JAMA 2003;290:476-485.
ABSTRACT | FULL TEXT  

Routine Vitamin Supplementation To Prevent Cancer and Cardiovascular Disease: Recommendations and Rationale
U.S. Preventive Services Task Force*
ANN INTERN MED 2003;139:51-55.
ABSTRACT | FULL TEXT  

Routine Vitamin Supplementation To Prevent Cardiovascular Disease: A Summary of the Evidence for the U.S. Preventive Services Task Force
Morris and Carson
ANN INTERN MED 2003;139:56-70.
ABSTRACT | FULL TEXT  

Dietary carotenoids and risk of coronary artery disease in women
Osganian et al.
Am. J. Clin. Nutr. 2003;77:1390-1399.
ABSTRACT | FULL TEXT  

Vitamins for Chronic Disease Prevention in Adults: Scientific Review
Fairfield and Fletcher
JAMA 2002;287:3116-3126.
ABSTRACT | FULL TEXT  

A Dietary Oxidative Balance Score of Vitamin C, {beta}-Carotene and Iron Intakes and Mortality Risk in Male Smoking Belgians
Van Hoydonck et al.
J. Nutr. 2002;132:756-761.
ABSTRACT | FULL TEXT  

Nutrition and Health Promotion in Older Adults
Chernoff
J. Gerontol. A Biol. Sci. Med. Sci. 2001;56:47-53.
ABSTRACT | FULL TEXT  

Antioxidant vitamin status and carotid atherosclerosis in the elderly
Gale et al.
Am. J. Clin. Nutr. 2001;74:402-408.
ABSTRACT | FULL TEXT  

Antioxidants in health and disease
Young and Woodside
J. Clin. Pathol. 2001;54:176-186.
ABSTRACT | FULL TEXT  

Randomized Trial of Supplemental {beta}-Carotene to Prevent Second Head and Neck Cancer
Mayne et al.
Cancer Res. 2001;61:1457-1463.
ABSTRACT | FULL TEXT  

Low Plasma Lycopene Concentration Is Associated With Increased Intima-Media Thickness of the Carotid Artery Wall
Rissanen et al.
Arterioscler. Thromb. Vasc. Bio. 2000;20:2677-2681.
ABSTRACT | FULL TEXT  

Serum Carotenoids and Markers of Inflammation in Nonsmokers
Kritchevsky et al.
Am J Epidemiol 2000;152:1065-1071.
ABSTRACT | FULL TEXT  

Multivitamin Use and Mortality in a Large Prospective Study
Watkins et al.
Am J Epidemiol 2000;152:149-162.
FULL TEXT  

Canthaxanthin Supplementation Alters Antioxidant Enzymes and Iron Concentration in Liver of Balb/c Mice
Palozza et al.
J. Nutr. 2000;130:1303-1308.
ABSTRACT | FULL TEXT  

{beta}-Carotene Does Not Change Markers of Enzymatic and Nonenzymatic Antioxidant Activity in Human Blood
Castenmiller et al.
J. Nutr. 1999;129:2162-2169.
ABSTRACT | FULL TEXT  

Alcohol, vitamin A, and {beta}-carotene: adverse interactions, including hepatotoxicity and carcinogenicity
Leo and Lieber
Am. J. Clin. Nutr. 1999;69:1071-1085.
ABSTRACT | FULL TEXT  

Evidence based cardiology: Emerging approaches in preventing cardiovascular disease
Lonn and Yusuf
BMJ 1999;318:1337-1341.
FULL TEXT  

Dietary antioxidants and risk of myocardial infarction in the elderly: the Rotterdam Study
Klipstein-Grobusch et al.
Am. J. Clin. Nutr. 1999;69:261-266.
ABSTRACT | FULL TEXT  

beta -Carotene, Carotenoids and the Prevention of Coronary Heart Disease
Kritchevsky
J. Nutr. 1999;129:5-8.
ABSTRACT | FULL TEXT  

Relationship of Plasma Carotenoids, Retinol and Tocopherols in Mothers and Newborn Infants
Yeum et al.
J. Am. Coll. Nutr. 1998;17:442-447.
ABSTRACT | FULL TEXT  

all-Trans-Retinoic Acid Reduces Neointimal Formation and Promotes Favorable Geometric Remodeling of the Rat Carotid Artery After Balloon Withdrawal Injury
Miano et al.
Circulation 1998;98:1219-1227.
ABSTRACT | FULL TEXT  

Meta-analysis Spurious precision? Meta-analysis of observational studies
Egger et al.
BMJ 1998;316:140-144.
FULL TEXT  

Unimpressive Results from Vitamin E,Beta Carotene
Journal Watch Dermatology 1996;1996:17-17.
FULL TEXT  

UNIMPRESSIVE RESULTS FROM TRIALS OF VITAMIN E, BETA CAROTENE
JWatch General 1996;1996:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.